FCMT
PJP icon

Founders Capital Management (Texas)’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Founders Capital Management (Texas)’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-731
Closed -$46K – 338
2018
Q1 		$46K Buy
731
+1
+0.1% +$66 0.04% 142
2017
Q4 		$47K Buy
730
+1
+0.1% +$64 0.04% 142
2017
Q3 		$48K Buy
729
+2
+0.3% +$126 0.04% 143
2017
Q2 		$46K Hold
727
– – 0.04% 143
2017
Q1 		$43K Buy
+727
New +$42.5K 0.04% 147

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Founders Capital Management (Texas)'s PJP Position: Q2 2018 in Review

Founders Capital Management (Texas) sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2018, closing a stake of 731 shares — an estimated $46K sold.

Founders Capital Management (Texas) first reported a position in PJP in Q1 2017 and held it in 5 quarters. The position peaked at $48K in Q3 2017. 85 funds tracked by Wall St. Rank hold PJP as of Q2 2018.

  • Founders Capital Management (Texas) reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2018 after selling out during the quarter.
  • Founders Capital Management (Texas) sold 731 Invesco Pharmaceuticals ETF shares in Q2 2018, an estimated $46K.
  • Founders Capital Management (Texas) first reported a position in Invesco Pharmaceuticals ETF in Q1 2017 and held it in 5 quarters.
  • Founders Capital Management (Texas)'s Invesco Pharmaceuticals ETF position peaked at $48K in Q3 2017.
  • 85 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2018.

Based on Founders Capital Management (Texas)'s 13F filing for Q2 2018, filed 9 Jul 2018.